Skip to content

Feasibility study on rapid pre-treatment method of perfusion device in acute poisoning blood perfusion treatment

Feasibility study on rapid pre-treatment method of perfusion device in acute poisoning blood perfusion treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089946
Enrollment
Unknown
Registered
2024-09-20
Start date
2024-09-23
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

poisoning

Interventions

Sponsors

Central People's Hospital of Zhanjiang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: ? Age range: 18~85 years old; ? Patients who meet the criteria for acute poisoning diagnosis in the Chinese Expert Consensus on Diagnosis and Treatment of Acute Poisoning (2016); ? The clinical treatment drugs for combined underlying diseases do not affect coagulation function (clinical doctors make judgments based on the instructions of the drugs used); ? Informed consent from patients or their families.

Exclusion criteria

Exclusion criteria: ? Patients who require combined hemodialysis or filtration; ? Vulnerable groups: such as pregnant women, children, and other special groups such as detainees; ? The patient or their family members are unwilling to cooperate with the examination.

Design outcomes

Primary

MeasureTime frame
Coagulation;Coagulation grading of perfusion apparatus;

Secondary

MeasureTime frame
Preprocessing duration;VAS (Ease of operation);

Countries

China

Contacts

Public ContactShiliang Ke

Central People's Hospital of Zhanjiang

haoyiksl@163.com+86 188 2610 8940

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026